共 50 条
Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
被引:26
|作者:
Chen, Yen-Ying
[1
,2
]
Yeh, Matthew M.
[3
,4
]
机构:
[1] Taipei Vet Gen Hosp, Dept Pathol & Lab Med, Taipei, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei, Taiwan
[3] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA
[4] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
关键词:
Fatty liver;
Nonalcoholic fatty liver disease;
Nonalcoholic steatohepatitis;
GLOBAL EPIDEMIOLOGY;
STEATOHEPATITIS;
PREVALENCE;
FIBROSIS;
NAFLD;
METAANALYSIS;
ASSOCIATION;
DIAGNOSIS;
STEATOSIS;
ALGORITHM;
D O I:
10.1016/j.jfma.2020.07.006
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in North America and Europe, with increasing prevalence in other regions of the world. Its spectrum encompass steatosis, non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis. It is considered as the manifestation of metabolic syndrome in liver, and its development and progression is influenced by complex interaction of environmental and genetic factors. In this review we discuss the histopathological features, differential diagnoses, and the commonly used grading and staging systems of NAFLD. NAFLD associated with other diseases, histological changes after therapeutic intervention and recurrence or occurrence of NAFLD after liver transplantation are also addressed. Copyright (C) 2020, Formosan Medical Association. Published by Elsevier Taiwan LLC.
引用
收藏
页码:68 / 77
页数:10
相关论文